Core Viewpoint - The bearish outlook from Ladenburg analyst Michael Legg has led to a significant sell-off in Nano Nuclear Energy stock, with shares dropping 18.9% over the week [2][4][5]. Group 1: Stock Performance - Nano Nuclear Energy stock experienced a decline of 18.9% from the end of last Friday's trading session to Thursday's market close [2]. - The stock started the week poorly after being downgraded to sell by Ladenburg, with a new price target set at $9, a significant drop from the previous target of $51 [4]. Group 2: Analyst Actions - Analyst Michael Legg's downgrade marks a stark change from July when the stock was initiated with a buy rating and a much higher price target [4]. - The bearish outlook from the analyst has had a considerable impact on investor sentiment, leading to continued selling through Wednesday [5]. Group 3: Company Developments - On Thursday, Nano Nuclear Energy reported advancement to the final round of the U.S. Army xTechSearch 9 competition, which may provide some positive news amidst the stock's decline [6]. - The U.S. Army's xTech program aims to engage with technology companies for critical defense applications, indicating potential future opportunities for the company [6]. Group 4: Investor Sentiment - Despite the recent sell-off, long-term investors may find the current situation less concerning, as analysts typically have shorter investment horizons [7]. - The recent developments with the U.S. Army are noteworthy but do not significantly alter the overall investment thesis for Nano Nuclear Energy [7].

Financial Data and Key Metrics Changes - Year to date loss from operations was $35.8 million, an increase of approximately $28 million from the comparable nine-month prior year period [43] - Year to date net loss totaled $32 million, up approximately $24 million from the prior year period, reflecting increases in R&D and G&A expenses [44] - Cash and cash equivalents increased to $210.2 million, an approximate $92 million increase from the end of the second fiscal quarter [45] Business Line Data and Key Metrics Changes - The company advanced its patented Cronos MMR energy system toward construction, demonstration, and licensing with the U.S. Nuclear Regulatory Commission (NRC) [20] - A strategic collaboration agreement was executed to build out the first Cronos MMR at the University of Illinois Urbana Champaign [21] - The company signed an MOU with UR America to explore strategic development across Argentina's uranium fuel supply chain [23] Market Data and Key Metrics Changes - Analysts project U.S. electricity consumption to rise at approximately 2.4% CAGR between 2022 and 2030, with data centers expected to comprise 8% of U.S. power by 2030 [12][13] - There is a growing global commitment to triple nuclear capacity by 2050, solidifying growth in nuclear energy as a secular trend for the coming decades [11] Company Strategy and Development Direction - The company is focused on a vertically integrated strategy to derisk microreactor development and enhance its competitive position [6][8] - The acquisition of Cronos MMR microreactor positions the company as a North American leader in microreactor commercialization [6] - The company aims to secure key stages of the nuclear fuel supply chain as a strategic priority [34] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to capitalize on macro trends driving demand for advanced nuclear solutions [9] - The company highlighted the importance of bipartisan legislative and policy support for nuclear energy, which has emerged as a strategic focus for national security and climate goals [14][15] - Management is optimistic about the future, citing a strong team and a clear vision for commercialization [17] Other Important Information - The company closed a private placement for net proceeds of $99 million, strengthening its balance sheet and expanding institutional ownership [9] - Recent personnel additions and collaborations validate the company's strong competitive position [25][27] Q&A Session Summary Question: Progress in Canada to license there - The company is focused on reengaging with the Canadian licensing process and has almost completed the legal process of taking the holding entity out of bankruptcy [51][52] Question: Commercial sales opportunities for ALIP - The company is completing the SBIR Phase three process with the DOE, which will enable it to become a default contractor for supplying ALIP technology [58] Question: Cash usage during the remainder of 2025 and into 2026 - The estimated cash burn over the next twelve months is around $40 million, primarily for hiring and operational support [68] Question: Strategy of vertical integration - The company is examining how to involve itself in upstream processes like mining, milling, and conversion to derisk the fuel supply chain [75] Question: Application for the DOE Advanced Reactor pilot program - The company did not apply for the DOE program as it would result in higher costs and no commercial benefit [80][82] Question: Supply chain for nuclear grade graphite - The company is negotiating with suppliers for components like nuclear grade graphite and reactor pressure vessels, which will need to be outsourced [87]

Core Viewpoint - NANO Nuclear Energy Inc. is positioned to capitalize on the growing demand for clean and reliable nuclear energy solutions, driven by regulatory support and advancements in technology, particularly through its KRONOS MMR Energy System [2][11]. Financial Results - The company reported a cash and cash equivalents balance of $210.2 million as of June 30, 2025, a significant increase from $28.5 million on September 30, 2024, due to successful capital raises [9]. - Operating activities resulted in a cash outflow of $14.7 million for the nine months ended June 30, 2025, primarily due to increased operations and R&D expenses [3]. - Investing activities accounted for a cash outflow of $12.9 million, including $9.1 million for the acquisition of assets like the KRONOS MMR [4]. - Financing activities provided a net cash inflow of $209.3 million during the same period [5]. Technological Advancements & Regulatory Progress - The KRONOS MMR is advancing towards licensing and deployment in the U.S., with significant progress made in collaboration with the University of Illinois Urbana-Champaign [9][11]. - The company has received an approved Fuel Qualification Methodology Topical Report from the NRC and is focused on resuming licensing activities in Canada [9][11]. - NANO Nuclear aims to be the first commercial microreactor company in the U.S. to file for a construction permit application by late 2025 or early 2026 [11][12]. Operational Progress & Leadership - NANO Nuclear has made key appointments to its leadership team, including Rick Perry as Chairman of the Executive Advisory Board and Seth Berl as an independent director, enhancing its strategic capabilities [10][13]. - The company has initiated a recruitment drive to expand its engineering and project development teams, successfully hiring over a dozen engineers [13]. Strategic Collaborations & Market Position - NANO Nuclear signed a Memorandum of Understanding (MOU) with UrAmerica to secure resources and enhance its nuclear fuel supply chain [10]. - The company has been selected for inclusion in the Solactive Global Uranium & Nuclear Components Total Return Index, qualifying it for the Global X Uranium ETF, which enhances its market visibility [10][12]. - NANO Nuclear is exploring opportunities for vertical integration through collaborations and potential mergers and acquisitions to strengthen its competitive position [11][12].

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission file number 001-42044 NANO NUCLEAR ENERGY INC. (Exact name of registrant as specified in its charter) | | | (State or othe ...

Company Overview - NANO Nuclear Energy Inc aims to be a commercial leader in the U S nuclear industry, focusing on advanced technology and vertical integration[10, 15] - The company's development strategy includes advanced microreactors, fuel processing, nuclear fuel transportation, and consultation services[11, 13] Reactor Designs and Technology - NANO Nuclear acquired KRONOS MMR in January 2025, a modular High Temperature Gas Reactor with a power output of 10 MWe to 1000 MWe (multiple units)[28, 32] - The KRONOS MMR project has received NRC approval for Fuel Qualification Methodology (FQM)[35] - The LOKI MMR is a portable reactor with a power output of 05 MWe to 3 MWe, designed for terrestrial, marine, and space environments[43, 47] - ZEUS is a solid core battery reactor, with patent applications filed in May 2025[50] - ODIN is a Low-Pressure Coolant Reactor, with strategic alternatives being considered to focus on KRONOS MMR[58, 60] Fuel Processing and Transportation - NANO Nuclear is a member of the DOE's HALEU Consortium, supporting the development of enrichment technology[67, 72] - The company is collaborating with LIS Technologies Inc to advance uranium enrichment and fuel fabrication capabilities[73, 75] - Advanced Fuel Transportation Inc (AFT) has secured exclusive licensing rights for a high-capacity HALEU fuel transport basket technology[84, 88] Facilities and Collaborations - NANO Nuclear acquired a 23,537-square-foot facility in Oak Brook, Illinois, to support KRONOS MMR development[94, 98] - A 14,000 sq ft facility was purchased in Oak Ridge, Tennessee in August 2024 for $171 million to support collaboration with LIS Technologies[100, 106] - A demonstration facility in Westchester County, NY, is used to demonstrate components of microreactor designs and ALIP technology[108, 111]

Group 1 - China Biopharmaceutical (1177.HK) saw a rise of over 3% after announcing a successful licensing agreement with Merck for its PD-1/VEGF dual antibody, expecting a $300 million milestone payment soon [1] - CSPC Pharmaceutical Group (1093.HK) increased by over 5% following the announcement of an exclusive licensing agreement with Madrigal Pharmaceuticals for the global development of its GLP-1 receptor agonist SYH2086 [1] - Youzan (8083.HK) surged over 7% as it projected a revenue of approximately 709 to 719 million RMB for the first half of the year, a year-on-year increase of about 3.3% to 4.8%, and a net profit of 68 to 74 million RMB, marking a turnaround from a loss last year [1] Group 2 - Xingsheng International (6058.HK) rose nearly 18% after the bank announced its commitment to embrace technological transformation and explore stablecoins and AI initiatives [2] - New Oriental Education (9901.HK) fell nearly 4% after reporting a 9.4% year-on-year increase in net revenue to $1.243 billion for the fourth quarter of fiscal year 2025, but a 73.7% drop in net profit [2] - Kingdee International (0268.HK) saw a rise of over 7% as it announced a board meeting to review its interim results and potential dividend distribution [2] Group 3 - Macau gaming stocks rose, with MGM China (2282.HK) up over 4% after Macquarie raised its forecast for Macau's total gaming revenue for 2025 by 5% to 235.7 billion RMB, indicating a year-on-year growth of 4% [3] - Gold stocks in Hong Kong continued to decline, with Tongguan Gold (0340.HK) dropping over 9% for six consecutive days, as spot gold prices fell below $3,270 per ounce [4] - Kangfang Biopharma (9926.HK) rose nearly 5% after announcing the completion of the first patient dosing in a pivotal clinical trial for its PD-1/VEGF dual-specific antibody [4] Group 4 - Weishi Jiajie (0856.HK) increased by over 3% as a report indicated that its Southeast Asia business is expected to see a significant revenue increase of 74% in 2024, with net profit contributing about 51% [5] Group 5 - Meta (META.US) exceeded revenue expectations and provided strong guidance for the current quarter, leading to an after-hours increase of over 11% [6] - Microsoft (MSFT.US) reported an 18% year-on-year growth in revenue, driven by its cloud business, with Azure revenue up 34% for the full year, resulting in an after-hours increase of over 8% [6] - Wingstop (WING.US) surged by 26.85% after reporting adjusted earnings per share of $1.00 for the second quarter, exceeding analyst expectations [6] Group 6 - Several biopharmaceutical stocks surged, with Replimune (REPL.US) up 101.33% following news of regulatory changes at the FDA that may ease pressure on gene therapy and vaccine companies [7] - Marvell Technology (MRVL.US) rose 7.07% after announcing a partnership with Rebellions to provide AI systems for regional projects in Asia-Pacific and the Middle East [7] - Palo Alto Networks (PANW.US) fell 5.58% after agreeing to acquire CyberArk Software for approximately $25 billion [8]

（文章来源：智通财经） 周三，核电板块走高，截至发稿，Oklo Inc(OKLO.US)涨超8%，NANO Nuclear(NNE.US)涨超5.8%， NuScale Power(SMR.US)涨超3%。 ...

Core Viewpoint - The nuclear power sector experienced a notable increase in stock prices, indicating positive market sentiment towards companies in this industry [1] Company Performance - Oklo Inc (OKLO.US) saw its stock price rise by over 8% [1] - NANO Nuclear (NNE.US) experienced a stock price increase of more than 5.8% [1] - NuScale Power (SMR.US) had a stock price increase of over 3% [1]

Core Points - NANO Nuclear Energy Inc. has acquired a 23,537-square-foot facility on 2.75 acres in Oak Brook, Illinois, to support the development of the KRONOS MMR™ Microreactor Energy System in collaboration with the University of Illinois Urbana-Champaign [2][3][10] - The facility will initially accommodate up to 60 nuclear engineers, researchers, and support staff for component construction and testing of the KRONOS MMR™, which is a high technology readiness level advanced micro modular reactor [3][6] - The acquisition cost was $3.5 million, and the facility includes a 7,400-square-foot non-nuclear demonstration area [3][4] Company Development - This facility marks NANO Nuclear's third U.S. facility and second dedicated to physical test work, enhancing its operational capacity in the advanced nuclear energy sector [5][9] - The company has engaged AECOM for site-specific engineering, environmental analysis, and regulatory planning at UIUC, laying the groundwork for deploying the first MMR™ [4][10] - NANO Nuclear aims to establish a strong presence in Illinois, which generated 54.89% of its electricity from nuclear power in 2023, making it an ideal location for next-generation reactor technologies [6][10] Strategic Goals - The new facility will serve as a central hub for advancing the KRONOS MMR™ towards construction, demonstration, regulatory licensing, and deployment [6][10] - NANO Nuclear is actively recruiting nuclear engineers and researchers to support its initiatives at the new facility, reflecting its growth in the advanced nuclear energy sector [6][10] - The location near the U.S.-Canada border positions NANO Nuclear to advance plans for bringing the KRONOS MMR™ to Canada and prepare for commercialization efforts across North America [9][10]

Core Viewpoint - NANO Nuclear Energy (NASDAQ: NNE) has shown a positive performance since February, despite experiencing volatility typical of the stock market in April [1] Company Summary - NANO Nuclear Energy has a beneficial long position in its shares, indicating confidence in its future performance [1]